documentCode: Y229
overlay: |
  The re-importation of certain tiered-priced medicines is illegal in order to prevent trade diversion from a number of low and middle-income countries.

  Goods subject to this import control are listed in:
  - GB: Annex I of the retained domestic version of [Regulation (EU) 2016/793](https://www.legislation.gov.uk/eur/2016/793/contents), as amended by the [Prevention of Trade Diversion (Key Medicines) (EU Exit) Regulations 2020](https://www.legislation.gov.uk/uksi/2020/1354/contents/made).
  - NI: Annex I of [Regulation (EU) 2016/793](https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32016R0793).

  Countries from which the import of these products is restricted are listed in:
  - GB: Annex II of the retained domestic version of [Regulation (EU) 2016/793](https://www.legislation.gov.uk/eur/2016/793/contents), as amended by the  [Prevention of Trade Diversion (Key Medicines) (EU Exit) Regulations 2020](https://www.legislation.gov.uk/uksi/2020/1354/contents/made).
  - NI: Annex II of [Regulation (EU) 2016/793](https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32016R0793).
  
  For more information see the [GOV.UK guidance on import controls](https://www.gov.uk/guidance/import-controls).
locale: EN